You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SEQUENTIAL THERAPY

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-cardiac Surgery Trial in Peshawar (Baduanjin sequential therapy, Conventional Therapy)

Recruiting
  • Post-cardiac Surgery
  • Baduanjin sequential therapy
  • Conventional Therapy
  • Peshawar, KPK, Pakistan
    Peshawar Institute of cardiology
May 17, 2023

Helicobacter Pylori Infection Trial in New Taipei City (Vonoprazan and Amoxicillin, Lansoprazole, Amoxicillin, Clarithromycin

Recruiting
  • Helicobacter Pylori Infection
  • Vonoprazan and Amoxicillin
  • Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital, Fu Jen Catholic University
Dec 3, 2023

H.Pylori Infection Trial in Liaocheng (clarithromycin-containing triple therapy, bismuth quadruple therapy, a PPI-amoxicillin

Recruiting
  • Helicobacter Pylori Infection
  • Liaocheng, Shandong, China
    Liaocheng people's hospital
Dec 15, 2022

Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Chemotherapy Effect
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Helicobacter Pylori Trial in New Taipei City (Vonoprazan-based triple therapy, Extended sequential therapy)

Recruiting
  • Helicobacter Pylori
  • Vonoprazan-based triple therapy
  • Extended sequential therapy
  • New Taipei City, Taiwan
    Fu Jen Catholic University Hospital
May 8, 2022

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Helicobacter Pylori Infection Trial in Karachi (Lactobacillus Reuteri Probiotic)

Completed
  • Helicobacter Pylori Infection
  • Lactobacillus Reuteri Probiotic
  • Karachi, Sindh, Pakistan
    Mehreen Akmal
Jan 18, 2023

Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to Trial in Karachi (Sequential Regimen:

Completed
  • Helicobacter Pylori Infection
  • Helicobacter Pylori Infection, Susceptibility to
  • Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID
  • Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID
  • Karachi, Sindh, Pakistan
    Jamal Noor Hospital, Karachi
May 8, 2023

AMI Trial in Shenyang (Baduanjin sequential therapy, Aerobic exercise)

Recruiting
  • AMI
  • Baduanjin sequential therapy
  • Aerobic exercise
  • Shenyang, Liaoning, China
    General Hospital of Shenyang Military Region
Jan 9, 2022

NSCLC Trial in Jinan (TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation, TQB2450 injection, sequential

Not yet recruiting
  • Non-small Cell Lung Cancer
  • TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation
  • TQB2450 injection, sequential or concurrent chemoradiation
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong First Medical University
May 5, 2023

Observes Afatinib as First-line Treatment and Sequential Therapy

Active, not recruiting
  • Non-squamous, Non-Small Cell Lung Cancer
  • Beijing, China
  • +9 more
Jan 9, 2023

Helicobacter Pylori Infection Trial in Damascus (sequential, Levofloxacin 500Mg Oral Tablet)

Not yet recruiting
  • Helicobacter Pylori Infection
  • Damascus, Syrian Arab Republic
    General Assembly of Damascus Hospital
Sep 27, 2023

Helicobacter Infections Trial in Shanghai (triple therapy, sequential therapy, bismuth quadruple therapy)

Recruiting
  • Helicobacter Infections
  • triple therapy
  • +3 more
  • Shanghai, Shanghai, China
    Children's hospital of Fudan university
Dec 8, 2022

NSCLC, Consolidation Immunotherapy, Radiotherapy or Sequential Chemoradiation Trial in Beijing (Tislelizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Beijing, China
    Peking University Cancer Hospital and Institute
Mar 4, 2023

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Osteoporosis Trial in Douliu (Alendronate)

Recruiting
  • Osteoporosis
  • Douliu, Yunlin County, Taiwan
    National Taiwan University Hospital, Yunlin branch
Oct 22, 2021

Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
  • +4 more
  • Guangzhou, Guangdong, China
    SUN Yat-sen University Cancer Center
Sep 11, 2023

Multiple Myeloma Trial in United States (KRdD followed by auto-HCT, KRdD only)

Active, not recruiting
  • Multiple Myeloma
  • KRdD followed by auto-HCT
  • KRdD only
  • Birmingham, Alabama
  • +3 more
Mar 26, 2022

Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • toripalimab FOLFOX
  • (no location specified)
Aug 3, 2023

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Stroke Trial in Saint Petersburg (Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo)

Recruiting
  • Stroke
  • Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
  • Placebo
  • Saint Petersburg, Russian Federation
  • +2 more
Jul 7, 2023

Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

Not yet recruiting
  • Gastric
  • Colorectal Adenocarcinoma
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Nov 1, 2023

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Osteoporosis, Bone Mineral Density Trial in Douliu (Denosumab)

Recruiting
  • Osteoporosis
  • Bone Mineral Density
  • Douliu, Yunlin County, Taiwan
    National Taiwan University Hospital, Yunlin branch
Oct 22, 2021